Drug Discovery

The pursuit of effective treatments for Duchenne muscular dystrophy has shifted focus toward managing cardiomyopathy, which currently stands as the most common cause of mortality for patients entering their second or third decade of life. Capricor Therapeutics recently faced significant headwinds

Mesothelioma has long remained one of the most difficult and aggressive cancers to treat within the modern medical landscape, primarily due to its ability to lie dormant for decades following asbestos exposure. By the time most patients receive a formal diagnosis, the disease has usually progressed

Recent breakthroughs in the field of molecular biology have unveiled a sophisticated biochemical mechanism that acts as a definitive binary toggle for malignant cellular proliferation, effectively governing the transition between dormant and aggressive tumor growth. For decades, oncologists

The intersection of computational intelligence and molecular biology has revealed a shocking source for the next generation of life-saving medicine: the same infectious proteins responsible for devastating neurological disorders like Creutzfeldt-Jakob disease. Researchers at the Perelman School of

The traditional image of a scientist tethered to a laboratory bench with a pipette and a manual notebook has rapidly evolved into a scenario where researchers manage complex experiments via high-speed internet connections and sophisticated cloud interfaces. This shift represents a fundamental

The persistent gap between the growing demand for organ transplants and the limited supply of donor tissues has driven researchers to seek more sophisticated bioengineering solutions for several decades. While the scientific community has successfully fabricated large-scale arteries and microscopic